This study performed whole-genome sequencing of single neurons isolated from prefrontal cortex (PFC) and hippocampus CA1 (HC) of postmortem human brain of individuals with Alzheimer’s disease (AD)(Braak stage V-VI) or non-disease control, along with bulk whole-genome sequencing performed on each individual as a reference genome for variant calling. Single neuron genomes were amplified using multiple-displacement amplification (MDA) or primary template-directed amplification (PTA).

Michael Miller
Brigham and Women’s Hospital

NIH K08 AG065502

Doris Duke Charitable Foundation Clinical Scientist Development Award 2021183

Acknowledgment statement for any data distributed by NIAGADS:

Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689), funded by the National Institute on Aging.

For investigators using Alzheimer’s disease single-neuron whole-genome sequencing – Miller 2022 data:

NIH Sponsoring Institute: NIA

Grant funding: NIH K08 AG065502

Doris Duke Charitable Foundation Clinical Scientist Development Award 2021183